Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.
about
Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidneyCyclooxygenase inhibition: between the devil and the deep blue seaImmunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetesNonsteroidal Anti-Inflammatory Drugs and the KidneyTopical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury.Topical nonsteroidal anti-inflammatory drugs for the treatment of pain due to soft tissue injury: diclofenac epolamine topical patch.Valdecoxib for the management of chronic and acute pain.High blood pressure in the geriatric population: treatment considerations.The treatment of pain in urology.Cyclooxygenase-2 inhibitor-associated acute renal failure: case report with rofecoxib and review of the literature.Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors.Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats.Maximizing the safety of nonsteroidal anti-inflammatory drug use for postoperative dental pain: an evidence-based approach.Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.Adverse Drug Events Involving COX-2 Inhibitors.Cardiovascular risk and COX-2 inhibition in rheumatological practice.Treatment strategies for osteoarthritis patients with pain and hypertension.A comparison of the analgesic effects of butorphanol with those of meloxicam after elective ovariohysterectomy in dogs.Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study.Analgesic Effects and Safety of Desmopressin, Tramadol and Indomethacin in Patients with Acute Renal Colic; A Randomized Clinical Trial.Albumin microspheres as carriers for the antiarthritic drug celecoxib.Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial.Electrolyte and Acid-base disturbances associated with non-steroidal anti-inflammatory drugs.Parecoxib reduces systemic inflammation and acute lung injury in burned animals with delayed fluid resuscitation.Renal adverse effects of nonsteroidal anti-inflammatory drugs.The adverse renal effects of prostaglandin-synthesis inhibition in the fetus and the newborn.Oxidative stress and cancer pain.Drug-induced hyperkalemia.Nanoparticles in drug delivery: mechanism of action, formulation and clinical application towards reduction in drug-associated nephrotoxicity.Drug Interactions with Lithium: An Update.Transient renal impairment in the absence of pre-existing chronic kidney disease in patients with unilateral ureteric stone impaction.Efficacy of celecoxib for acute pain management following total hip arthroplasty in elderly patients: A prospective, randomized, placebo-control trialAn evaluation of the analgesic effects of meloxicam in addition to epidural morphine/mepivacaine in dogs undergoing cranial cruciate ligament repair.Inhaled nitric oxide prevents NSAID-induced renal impairment in pseudo-normovolaemic piglets.Diclofenac induced acute renal failure in a decompensated elderly patient.Comparison of changes in blood pressure measurements and antihypertensive therapy in older, hypertensive, ambulatory care patients prescribed celecoxib or rofecoxib.Safe drug prescribingA life-threatening interaction between lithium and celecoxib.A possible interaction between lithium and rofecoxib.Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients.
P2860
Q26771378-09E0C6E6-9719-48AB-A188-9CAAB8FC43D7Q28192790-04004E41-73AF-46E1-8539-9776DEDE59DBQ28361901-87AD360F-70F3-43B4-B560-4C4A73C87DEFQ28386844-4D1A79FB-D0CC-4EC7-A4E6-46BCA9D1E612Q34322112-F290C2AE-1FB4-4B4E-98D4-BA24C7F50359Q34418290-69F9C1E2-7D7D-44AC-80AF-D3A99FD46116Q34557067-F23EA0A8-E35B-4F33-AFCB-6D477C0D56B7Q34714754-52C01212-DA4F-4F11-BA31-B1FBF62A55BFQ34783455-2A1F3789-1D83-4922-B93B-C744865B9134Q34975682-B6569014-508F-4317-BC59-058796DBA920Q35083808-F643C41C-49B1-4E16-9D9C-CDFDF017C5EAQ35106649-A08FC18E-DED5-4A0B-B426-E02EB0615751Q35179307-5F27EBF0-2272-49EA-B142-FCE3B1AAF245Q35195182-609A5002-B43E-4B95-B598-503E89587D4EQ35201026-7EA6A077-F4DB-476A-91B9-C561F53F3241Q35896154-B711D495-1211-4021-96C3-B4A7288B97C8Q36059512-94CEE168-AFC6-487B-ADBB-C8A69C490628Q36108547-A50FA207-D073-47AC-86EE-E65A697DFDBDQ36255870-96A9887D-F0EC-421A-A734-FBE7161ECA69Q36631125-FCC6302A-F792-494D-A758-D805B7A5A518Q37360677-BE2EBE31-6959-48FB-B5BF-89856508B0AEQ37386549-827BCB8D-6378-41DD-B027-D7461C370198Q37489103-FE74FF35-983F-432C-9DF5-BFD613964637Q37570964-78EACB92-45E4-4375-B978-AC09358CD9F5Q37615395-CFD2EC03-4132-4623-940D-D5A53AD2172AQ37666573-E881778E-19CC-49A0-B537-959837501CE0Q38078000-53A91C1F-C0F8-4F0E-90E9-3D6F8D7486F3Q38232308-340EE3AD-B4CD-4001-8045-555D3BB2115EQ38233071-D9DC09E1-4285-4C58-944B-426D6F8887BFQ38758442-8B205605-EBE8-4E02-888B-E0F21259BC33Q39170268-69420CF9-2750-46FF-80AB-D27B184F2931Q39180018-9D409E1E-E969-44CF-BFEC-F5E1591F975CQ40563706-18986277-3945-474B-B0E5-3EABF3D72902Q41013563-7088E0EC-18AE-4C6C-89DA-DA8C689936FCQ41347671-A7E0CF13-1E01-49B0-AA4E-57DDC1F8EF1CQ42613243-0DA6C2D4-31CE-4715-AF54-BA056205B873Q42759925-F703DB84-9B16-4878-95E2-E28266F023A2Q42760216-79CFDC73-7E26-498F-8587-25C939490706Q42780481-EC6CACB6-2E11-4BD8-B131-AC57AD27591DQ43754377-DEBC4591-1AFC-4149-A51C-82DBCD2B8CE4
P2860
Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Effects of nonsteroidal anti-i ...... genase-2-selective inhibition.
@ast
Effects of nonsteroidal anti-i ...... genase-2-selective inhibition.
@en
type
label
Effects of nonsteroidal anti-i ...... genase-2-selective inhibition.
@ast
Effects of nonsteroidal anti-i ...... genase-2-selective inhibition.
@en
prefLabel
Effects of nonsteroidal anti-i ...... genase-2-selective inhibition.
@ast
Effects of nonsteroidal anti-i ...... genase-2-selective inhibition.
@en
P1476
Effects of nonsteroidal anti-i ...... genase-2-selective inhibition.
@en
P2093
D C Brater
P304
65S-70S; discussion 70S-71S
P356
10.1016/S0002-9343(99)00369-1
P407
P577
1999-12-01T00:00:00Z